{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:54:41Z","timestamp":1793915681319,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nmd.2019.11.008","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T12:11:44Z","timestamp":1574338304000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Paediatric myasthenia gravis: Prognostic factors for drug free remission"],"prefix":"10.1016","volume":"30","author":[{"given":"Domizia","family":"Vecchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithara","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinki","family":"Munot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rodr\u00edguez Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Jayawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"DeVile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hilton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2019.11.008_bib0001","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0002","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1469-8749.2007.00629.x","article-title":"Childhood myasthenia: clinical subtypes and practical management","volume":"49","author":"Parr","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0003","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejpn.2016.09.001","article-title":"Juvenile myasthenia gravis in Norway: a nationwide epidemiological study","volume":"21","author":"Popperud","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3988\/jcn.2016.12.3.340","article-title":"Incidence and prevalence of Myasthenia gravis in Korea: a population-based study using the national health insurance claims database","volume":"12","author":"Park","year":"2016","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0005","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/WNL.37.12.1854","article-title":"Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians","volume":"12","author":"Chiu","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.11.008_bib0006","first-page":"5","article-title":"Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms","volume":"27","author":"Phillips","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.nmd.2019.11.008_bib0007","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mus.25965","article-title":"Clinical features and evolution of juvenile myasthenia gravis in a French cohort","volume":"57","author":"Barraud","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2019.11.008_bib0008","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2019.11.008_bib0009","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and pathogenic relevance of antibodies to clustered acetyl-choline receptor in ocular and generalised myasthenia gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0010","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2019.11.008_bib0011","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamaneurol.2015.0203","article-title":"Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative Mmyasthenia gravis","volume":"72","author":"Rodr\u00edguez Cruz","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0012","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1469-8749.2008.02038.x","article-title":"Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children","volume":"50","author":"Pitt","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. task force of the medical scientific advisory board of the Myasthenia gravis foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.11.008_bib0014","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1212\/WNL.10.11.1007","article-title":"Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescence: a study of 51 patients","volume":"10","author":"Millichap","year":"1960","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.11.008_bib0015","unstructured":"Office for National Statistics, 2011, UK"},{"key":"10.1016\/j.nmd.2019.11.008_bib0016","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1212\/WNL.44.7.1208","article-title":"Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis","volume":"44","author":"Andrews","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.11.008_bib0017","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/088307380201700516","article-title":"Gender prevalence in childhood multiple sclerosis and myasthenia gravis","volume":"17","author":"Haliloglu","year":"2002","journal-title":"J Child Neurol."},{"key":"10.1016\/j.nmd.2019.11.008_bib0018","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0960-8966(98)00077-7","article-title":"Juvenile myasthenia gravis with prepubertal onset","volume":"8","author":"Evoli","year":"1998","journal-title":"Neuromuscular Disorders"},{"issue":"9","key":"10.1016\/j.nmd.2019.11.008_bib0019","first-page":"7","article-title":"Clinical characteristics of juvenile Myasthenia gravis in Southern China","volume":"27","author":"Huang","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7196\/SAMJ.5390","article-title":"The characteristics of juvenile myasthenia gravis among South Africans","volume":"102","author":"Heckmann","year":"2012","journal-title":"S Afr Med J"},{"key":"10.1016\/j.nmd.2019.11.008_bib0021","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1177\/0883073816666206","article-title":"Juvenile myasthenia gravis in Korea: subgroup analysis according to sex and onset age","volume":"31","author":"Lee","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0022","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0161-6420(99)00138-4","article-title":"The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children","volume":"107","author":"Mullaney","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.nmd.2019.11.008_bib0023","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajo.2010.05.002","article-title":"Visual and systemic outcomes in pediatric ocular myasthenia gravis","volume":"150","author":"Pineles","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0024","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pediatrneurol.2018.06.007","article-title":"Juvenile ocular myasthenia gravis: presentation and outcome of a large cohort","volume":"87","author":"Vanikieti","year":"2018","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1179\/1465328111Y.0000000042","article-title":"Myasthenia gravis in Jamaican children: a 12-year institutional review","volume":"32","author":"Melbourne Chambers","year":"2012","journal-title":"Paediatr Int Child Health"},{"key":"10.1016\/j.nmd.2019.11.008_bib0026","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mus.25965","article-title":"Clinical features and evolution of juvenile myasthenia gravis in a French cohort","volume":"57","author":"Barraud","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2019.11.008_bib0027","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in Myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2019.11.008_bib0028","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mus.25205","article-title":"Factors affecting outcome in myasthenia gravis","volume":"54","author":"Andersen","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2019.11.008_bib0029","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial","volume":"18","author":"Wolfe","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2019.11.008_bib0030","unstructured":"MG Foundation of America post-interventional status, www.myasthenia.org"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619312064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619312064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:23Z","timestamp":1760774963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896619312064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0960896619312064"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2019.11.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paediatric myasthenia gravis: Prognostic factors for drug free remission","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2019.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}